Etanercept
| Use attributes for filter ! | |
| Formula | C2224H3475N621O698S36 |
|---|---|
| Molar mass | 51234. 9 g/mol g·mol−1 |
| Other names | etanercept-szzs, etanercept-ykro |
| Trade name | Enbrel, Benepali |
| Elimination half-life | 70–132 hours |
| Metabolism | Reticuloendothelial |
| Music groups | Adalimumab |
| Infliximab | |
| Methotrexate | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951166 |
About Etanercept
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor by acting as a TNF inhibitor.